Radiation Oncology

You are here

Clinical Trials

clinical trials group photo

Accepting new patients

(last updated 12/13/2019)

Prone partial breast irradiation (PBI): Prospective randomized controlled non-inferiority trial to compare radiation fibrosis with five versus three fractions (NCT02755896) 

  • IRB # 1505016201

Accelerated Radiation Therapy (ART) To the Breast and Nodal Stations after Neo-Adjuvant Chemotherapy and Surgery: A Feasibility Study (NCT02917421)

  • IRB # 1602017017    

Radiation and immune checkpoints blockade in metastatic NSCLC (BMS # CA209-632) (NCT03168464)

  • IRB # 1607017434

Effect of radiotherapy variables on circulating effectors of immune response and local microbiome (NCT03383107)

  • IRB # 1708018471 

Pembrolizumab and Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients (NCT03449238)

  • IRB # 1710018694

PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) (NCT03663218)

  • IRB # 1712018849

 Prospective Randomized study of Accelerated Radiation Therapy (PRART) (NCT04175210)

  • IRB # 19-07020533



Not accepting any new patients. 

last updated  12/13/2019

Converting HR+ Breast Cancer Into an Individualized Vaccine (NCT03804944)

  • IRB # 1808019498


RTOG0534: A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only RT (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy (NCT00567580)  

  • IRB # 0810010069 

An Open-Label Multicenter Phase 1b Study of E7046 in Combination with Radiotherapy/ Chemo radiotherapy (RT/CRT) in preoperative treatment of Subjects with Rectum Cancer (NCT03152370)

  • IRB # 1612017834

NRG GU003 - A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT) (NCT03274687)

  • IRB # 1708018460

MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer (SIBRT) (NCT03664193)

  • IRB # 1802019010

A Phase II randomized controlled trial of PD-1/PDL-1 axis blockade versus PD-1/PDL-1 axis blockade plus radiotherapy in metastatic genitourinary (renal/urothelial) malignancies (NCT03115801)

  • IRB # 1606017369   


Closed studies. 

last updated 12/13/2019

Randomized trial of image-guided stereotactic radiation therapy  (IG-SRT) in prostate cancer (NCT02911922)

  • IRB # 1604017139 

A First-in-Human Study of Repeat Dosing with REGN2810, a Monoclonal, Fully Human Antibody to Programmed Death - 1 (PD-1), as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies (NCT02383212)

  • IRB # 1505016229

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer (NCT02538471)

  • IRB # 1505016222

Phase I/II study of TLR7 agonist Imiquimod, Cyclophosphamide, and Radiotherapy in Breast Cancer Patients with Chest Wall Recurrence or Skin Metastases (NCT01421017)

  • IRB # 1505016228


 group photo

Clinical Trials Contact Information

Stich Radiation Oncology Clinical Trials

Maria Fenton-Kerimian,N.P.
Tel: (212) 746-6074

Sharanya Chandrasekhar
Tel: (646) 962-2196
email: shc2043@med.cornell.edu

Pragya Yadav
Tel: (646) 962-2199
email: pry2003@med.cornell.edu

Vijayalakshmi Nagaraj
Tel: (646) 962-3118
email: vin2009@med.cornell.edu

Contact Us

David H. Koch Center

New York-Presbyterian Hospital/
Weill Cornell Medical Center
1283 York Avenue, 4th floor
New York, NY 10065
Tel: (212) 746-3600
View Map

Stich Radiation Oncology Center

New York-Presbyterian Hospital/
Weill Cornell Medical Center
525 East 68th Street
New York, NY 10065
Tel: (212) 746-3600
View Map

The Arnold Center For Radiation Oncology

New York Hospital Queens
56-45 Main Street
(56th Avenue between Main Street and 141st Street)
Flushing, NY 11355
Tel: (718) 670-1501

View Map

New York-Presbyterian/
Lower Manhattan Cancer Center

21 West Broadway
New York, NY 10003
Tel: (212) 746-6600

View Map